Synthesis of N-Butanoylhomoserine Lactone
J. Chin. Chem. Soc., Vol. 54, No. 3, 2007 805
1.67 (m, 2H), 0.98 (t, J = 7.5 Hz, 3H); 13C NMR (75 MHz,
CDCl3) d 207.53, 172.99, 172.13, 55.32, 53.21, 52.93,
40.36, 36.82, 18.06, 13.94; Anal. Calcd for C10H15NO4: C,
56.33; H, 7.09; N, 6.57. Found: C, 56.69; H, 6.77; N, 6.96.
ACKNOWLEDGMENT
The authors would like to thank the National Science
Council (NSC-95-2113-M-390-003-MY2) of the Republic
of China for financial support.
(2S)-3-Butyryl-6-oxo-[1,3]oxazinane-4-carboxylic acid
methyl ester (5)
To a solution of m-chloroperoxybenzoic acid (6.0 g,
75%, 26.1 mmol) in dichloromethane (30 mL) was added a
solution of compound 4 (2.2 g, 10.3 mmol) and sodium car-
bonate (4.3 g, 40.6 mmol) in dichloromethane (30 mL) at 0
°C. The reaction mixture was stirred at rt for 20 h. Saturated
sodium carbonate solution (10 mL) was added to the reac-
tion mixture and the solvent was concentrated. The residue
was extracted with ethyl acetate (3 ´ 50 mL). The com-
bined organic layers were washed with brine, dried, filtered
and evaporated to afford crude product. Purification on sil-
ica gel (hexane/ethyl acetate = 4/1~2/1) afforded lactone
compound 5 (1.47 g, 62%) as the rotamers. HRMS (ESI,
M++1) calcd for C10H16NO5 230.1029, found 230.1026; 1H
NMR (300 MHz, CDCl3) d 5.60 (d, J = 10.5 Hz, 1H), 5.38
(d, J = 10.5 Hz, 1H), 4.91-4.82 (m, 1H), 3.74 (s, 3H), 3.09
(dd, J = 10.5, 18.9 Hz, 1H), 2.64 (dd, J = 2.7, 18.9 Hz, 1H),
2.25 (t, J = 7.5 Hz, 2H), 1.76-1.61 (m, 2H), 0.99 (t, J = 7.5
Hz, 3H); Anal. Calcd for C10H15NO5: C, 52.40; H, 6.60; N,
6.11. Found: C, 52.69; H, 6.72; N, 6.36.
Received September 4, 2006.
REFERENCES
1. Remuzon, P. Tetrahedron 1996, 52, 13803.
2. (a) Azizian, J.; Karimi, A. R.; Kazemizadeh, Z.; Mohammadi,
A. A.; Mohammadizadeh, M. R. J. Org. Chem. 2005, 70,
1471. (b) Honda, T.; Takahashi, R.; Namiki, H. J. Org.
Chem. 2005, 70, 499. (c) Qiu, X.-L.; Qing, F.-L. Bioorg.
Med. Chem. 2005, 13, 277. (d) Pandey, G.; Lakshmaiah, G.
Synlett 1994, 277. (e) Han, G.; LaPorte, M. G.; Folmer, J. J.;
Werner, K. M.; Weinreb, S. M. J. Org. Chem. 2000, 65,
6293. (f) Tamura, O.; Yanagimachi, T.; Ishibashi, H. Tetra-
hedron: Asymmetry 2003, 14, 3033. (g) Hu, H.; Zhai, H.
Synlett 2003, 2129. (h) Chang, M. Y.; Chen, S. T.; Chang, N.
C. Heterocycles 2003, 60, 1203. (i) Chang, M. Y.; Chen, H.
P. Heterocycles 2005, 65, 1705. (j) Chang, M. Y.; Chen, H.
P.; Lin, C. Y.; Pai, C. L. Heterocycles 2005, 60, 1999. (k)
Chang, M. Y.; Pai, C. L.; Chen, H. P. Tetrahedron Lett. 2005,
46, 7705.
3. (a) Richards, M. J.; Edwards, J. R.; Culver, D. H.; Gaynes, R.
P. Crit. Care Med. 1999, 27, 887. (b) Van Delden, C.; Iglewski,
B. H. Emerg. Infect. Dis. 1998, 4, 551. (c) Pearson, J. P.;
Passador, L.; Iglewski, B. H.; Greenberg, E. P. Proc. Natl.
Acad. Sci. USA 1995, 92, 1490. (d) Pearson, J. P.; Gray, K.
M.; Passador, L.; Tucker, K. D.; Eberhard, B. H.; Iglewski,
B. H.; Greenberg, E. P. Proc. Natl. Acad. Sci. USA 1994, 91,
197.
N-Butanoylhomoserine lactone (C4-HSL, 2)
A solution of diisobutylaluminum hydride (12.0 mL,
1.0 M in hexane, 12.0 mmol) was added to a solution of
compound 5 (1.15 g, 5.0 mmol) in tetrahydrofuran (10 mL)
at -78 °C. After 1.5 h, hydrogen chloride solution (6N, 10
mL) was added to the reaction mixture. After 20 min, the
reaction was warmed slowly to 0 °C and the solvent was
concentrated. The residue was extracted with ethyl acetate
(3 ´ 50 mL). The combined organic layers were washed
with brine, dried, filtered and evaporated to afford crude
product. Purification on silica gel (hexane/ethyl acetate =
2/1) afforded compound 2 (560 mg, 65%). IR (CHCl3)
3288, 1769, 1651, 1537, 1179 cm-1; HRMS (ESI, M++1)
calcd for C8H14NO3 172.0974, found 172.0977; 1H NMR
(300 MHz, CDCl3) d 6.06 (br s, 1H), 4.60-4.51 (m, 1H),
4.47 (t, J = 9.0 Hz, 1H), 4.28 (ddd, J = 6.0, 9.0, 11.4 Hz,
1H), 2.91-2.80 (m, 1H), 2.23 (t, J = 6.9 Hz, 2H), 2.23-2.05
4. (a) Bycroft, B. W.; Sewell, H. F.; Stewart, G.; Williams, P.
WO 95/01175, 1995. (b) Ko, D.-H.; Kim, D. J.; Lyu, C. S.;
Min, I. K.; Moon, H.-s. Tetrahedron Lett. 1998, 39, 297. (c)
Ikeda, T.; Kajiyama, K.; Kita, T.; Takiguchi, N.; Kuroda, A.;
Kato, J.; Ohtaake, H. Chem. Lett. 2001, 314. (d) Glansdorp,
F. G.; Thomas, G. L.; Lee, J. K.; Dutton, J. M.; Salmond, G.
P. C.; Welch, M.; Spring, D. R. Org. Biomol. Chem. 2004,
3329. (e) Tateda, K.; Ishii, Y.; Horikawa, M.; Matsumoto, T.;
Miyairi, S.; Pechere, J. C.; Standiford, T. J.; Ishiguro, M.;
Yamaguchi, K. Infect. Immun. 2003, 71, 5785. (f) Horikawa,
M.; Tateda, K.; Tuzuki, E.; Ishii, Y.; Ueda, C.; Takabatake,
T.; Miyairi, S.; Yamaguchi, K.; Ishiguro, M. Bioorg. Med.
Chem. Lett. 2006, 16, 2130.
(m, 1H), 1.73-1.62 (m, 2H), 0.96 (t, J = 7.2 Hz, 3H); 13
C
NMR (75 MHz, CDCl3) d 175.76, 173.82, 66.33, 49.47,
38.26, 30.87, 19.09, 13.89.